Clinical Trial Update: MK2206 in Treating Patients With Advanced Liver Cancer That Did Not Respond to Previous Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for MK-2206 in adults with advanced hepatocellular carcinoma that did not respond to prior therapy; the study was terminated and r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• MK-2206 (MK-2206)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Hepatocellular Carcinoma, Advanced Adult Hepatocellular Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2015-10-05